StockData

Zhengye Biotechnology Holding Ltd (ZYBT) stock

ZYBTNasdaqPharmaceutical Preparations
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 28, 2026Score 4/30
$1.52+0.09 (+6.29%)

Close on Nov 17, 2026Market cap $72.03MP/E –Yield –

Zhengye Biotechnology ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2025 it was -CN¥44.62M, down 209.9% from the year before.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025-CN¥44.62M-209.9%
FY2024Dec 31, 2024CN¥40.60M-41.1%
FY2023Dec 31, 2023CN¥68.90M-18.6%
FY2022Dec 31, 2022CN¥84.63M–

More Zhengye Biotechnology figures

See a number that looks wrong?